Skip to Content
Merck
  • Reducing intestinal nematode infection: efficacy of albendazole and mebendazole.

Reducing intestinal nematode infection: efficacy of albendazole and mebendazole.

Parasitology today (Personal ed.) (2000-02-01)
A Bennett, H Guyatt
ABSTRACT

The widespread use of mebendazole and albendazole for treating intestinal nematode infections in human populations is raising concerns that careful monitoring pro- cedures should be in place to identify any emergence of drug resistance. In this article, Andy Bennett and Helen Guyatt discuss whether benchmark parasitological drug efficacy rates can be defined for these anthelmintics, by analysing published data on cure rates and egg reduction rates in the treatment of Ascaris lumbricoides, Trichuris trichiura and hookworm.

MATERIALS
Product Number
Brand
Product Description

USP
Mebendazole, United States Pharmacopeia (USP) Reference Standard
Mebendazole, European Pharmacopoeia (EP) Reference Standard
Supelco
Mebendazole, analytical standard, ≥98% (HPLC)
Supelco
Mebendazole, VETRANAL®, analytical standard
Mebendazole for system suitability, European Pharmacopoeia (EP) Reference Standard